Feb 19, 2026 04:01PM
Feb 3, 2026 08:29AM
Feb 3, 2026 08:29AM
Jan 23, 2026 12:56PM
Jan 9, 2026 03:20AM
Nov 7, 2025 04:05PM
Nov 7, 2025 04:05PM Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
Oct 30, 2025 04:01PM
Oct 28, 2025 08:02AM
Oct 28, 2025 08:01AM
Oct 21, 2025 08:00AM
May 6, 2025 08:02AM
May 6, 2025 08:01AM
Apr 24, 2025 08:01AM Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference
Apr 10, 2025 04:03PM
Apr 10, 2025 04:02PM
Mar 31, 2025 04:04PM
Mar 31, 2025 04:03PM
Feb 20, 2025 07:30AM
Nov 8, 2024 12:34PM
Nov 8, 2024 12:31PM Ardelyx Responds to District Court Decision Granting Motion to Dismiss
Nov 8, 2024 12:31PM
Oct 24, 2024 04:06PM
Oct 24, 2024 04:05PM
Oct 15, 2024 08:00AM
Oct 9, 2024 08:05AM
Oct 9, 2024 08:05AM
Jul 31, 2024 08:02AM Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion
Jul 17, 2024 05:10PM
May 21, 2024 08:02AM
May 16, 2024 08:01AM
May 7, 2024 08:01AM
May 2, 2024 04:02PM
May 1, 2024 08:00AM
Feb 22, 2024 04:01PM Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Jan 8, 2024 08:05AM
Jan 8, 2024 08:00AM
Jan 3, 2024 08:03AM
Nov 15, 2023 04:02PM
Nov 15, 2023 04:02PM
Nov 13, 2023 04:03PM
Nov 13, 2023 04:02PM Ardelyx Announces Departure of Board Member
Nov 6, 2023 08:02AM
Nov 6, 2023 08:00AM
Nov 3, 2023 08:00AM
Nov 3, 2023 08:00AM
Oct 31, 2023 07:00AM
Oct 23, 2023 08:07AM
Oct 23, 2023 08:07AM Ardelyx Shares Positive Data on Symptom Response During Treatment With IBSRELA® (tenapanor) for IBS-C and hosts IBS-C Product Theater at ACG 2023
Oct 18, 2023 05:05AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All